The store will not work correctly when cookies are disabled.
2-(4-(2-(5-(2-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)ethoxy)benzylidene)malononitrile
ID: ALA2296208
PubChem CID: 76309422
Max Phase: Preclinical
Molecular Formula: C20H13ClN4O2S
Molecular Weight: 408.87
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: N#CC(C#N)=Cc1ccc(OCCSc2nnc(-c3ccccc3Cl)o2)cc1
Standard InChI: InChI=1S/C20H13ClN4O2S/c21-18-4-2-1-3-17(18)19-24-25-20(27-19)28-10-9-26-16-7-5-14(6-8-16)11-15(12-22)13-23/h1-8,11H,9-10H2
Standard InChI Key: UHHNGUJLUYHWMP-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
17.7388 -9.2794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5542 -9.2806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9611 -8.5761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5537 -7.8700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7352 -7.8728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3320 -8.5779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7783 -8.5763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2577 -9.2347 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.0359 -8.9822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0348 -8.1639 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.2559 -7.9134 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.7516 -9.3764 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
22.4512 -8.9540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4351 -8.1369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1346 -7.7145 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.8502 -8.1091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8609 -8.9240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5757 -9.3186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2762 -8.8961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2574 -8.0748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5422 -7.6840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9923 -9.2897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6913 -8.8664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4074 -9.2600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6742 -8.0493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6603 -7.2367 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.1202 -9.6537 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.9612 -7.1616 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
3 7 1 0
8 9 1 0
7 8 1 0
9 10 2 0
10 11 1 0
11 7 2 0
9 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
19 22 1 0
22 23 2 0
23 24 1 0
23 25 1 0
25 26 3 0
24 27 3 0
4 28 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 408.87 | Molecular Weight (Monoisotopic): 408.0448 | AlogP: 4.99 | #Rotatable Bonds: 7 |
Polar Surface Area: 95.73 | Molecular Species: NEUTRAL | HBA: 7 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 4.48 | CX LogD: 4.48 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.31 | Np Likeness Score: -1.95 |
References
1. Deora GS, Karthikeyan C, Moorthy NSHN, Rathore V, Rawat AK, Tamrakar AK, Srivastava AK, Trivedi P. (2013) Design, synthesis and biological evaluation of novel arylidine-malononitrile derivatives as non-carboxylic inhibitors of protein tyrosine phosphatase 1B, 22 (11): [10.1007/s00044-013-0528-1] |